305 related articles for article (PubMed ID: 17980894)
1. Validation of a stable recombinant antibodies repertoire for the direct selection of functional intracellular reagents.
Villani ME; Di Carli M; Donini M; Traversini G; Lico C; Franconi R; Benvenuto E; Desiderio A
J Immunol Methods; 2008 Jan; 329(1-2):11-20. PubMed ID: 17980894
[TBL] [Abstract][Full Text] [Related]
2. A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold.
Desiderio A; Franconi R; Lopez M; Villani ME; Viti F; Chiaraluce R; Consalvi V; Neri D; Benvenuto E
J Mol Biol; 2001 Jul; 310(3):603-15. PubMed ID: 11439027
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
4. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
5. Selecting for antibody scFv fragments with improved stability using phage display with denaturation under reducing conditions.
Brockmann EC; Cooper M; Strömsten N; Vehniäinen M; Saviranta P
J Immunol Methods; 2005 Jan; 296(1-2):159-70. PubMed ID: 15680160
[TBL] [Abstract][Full Text] [Related]
6. Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor.
Hyland S; Beerli RR; Barbas CF; Hynes NE; Wels W
Oncogene; 2003 Mar; 22(10):1557-67. PubMed ID: 12629519
[TBL] [Abstract][Full Text] [Related]
7. Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand.
Albrecht H; Burke PA; Natarajan A; Xiong CY; Kalicinsky M; DeNardo GL; DeNardo SJ
Bioconjug Chem; 2004; 15(1):16-26. PubMed ID: 14733579
[TBL] [Abstract][Full Text] [Related]
8. In vitro folding and thermodynamic stability of an antibody fragment selected in vivo for high expression levels in Escherichia coli cytoplasm.
Martineau P; Betton JM
J Mol Biol; 1999 Oct; 292(4):921-9. PubMed ID: 10525415
[TBL] [Abstract][Full Text] [Related]
9. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
10. Isolating and engineering human antibodies using yeast surface display.
Chao G; Lau WL; Hackel BJ; Sazinsky SL; Lippow SM; Wittrup KD
Nat Protoc; 2006; 1(2):755-68. PubMed ID: 17406305
[TBL] [Abstract][Full Text] [Related]
11. A universal strategy for stable intracellular antibodies.
Shaki-Loewenstein S; Zfania R; Hyland S; Wels WS; Benhar I
J Immunol Methods; 2005 Aug; 303(1-2):19-39. PubMed ID: 16045924
[TBL] [Abstract][Full Text] [Related]
12. High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm.
Venturi M; Seifert C; Hunte C
J Mol Biol; 2002 Jan; 315(1):1-8. PubMed ID: 11771962
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin fusions increase folding of single chain Fv antibodies in the cytoplasm of Escherichia coli: evidence that chaperone activity is the prime effect of thioredoxin.
Jurado P; de Lorenzo V; Fernández LA
J Mol Biol; 2006 Mar; 357(1):49-61. PubMed ID: 16427080
[TBL] [Abstract][Full Text] [Related]
14. Direct selection of antibodies from complex libraries with the protein fragment complementation assay.
Koch H; Gräfe N; Schiess R; Plückthun A
J Mol Biol; 2006 Mar; 357(2):427-41. PubMed ID: 16442560
[TBL] [Abstract][Full Text] [Related]
15. Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli.
Jurado P; Ritz D; Beckwith J; de Lorenzo V; Fernández LA
J Mol Biol; 2002 Jun; 320(1):1-10. PubMed ID: 12079330
[TBL] [Abstract][Full Text] [Related]
16. A fast mutagenesis procedure to recover soluble and functional scFvs containing amber stop codons from synthetic and semisynthetic antibody libraries.
Barderas R; Shochat S; Martínez-Torrecuadrada J; Altschuh D; Meloen R; Ignacio Casal J
J Immunol Methods; 2006 May; 312(1-2):182-9. PubMed ID: 16674972
[TBL] [Abstract][Full Text] [Related]
17. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
[TBL] [Abstract][Full Text] [Related]
18. Multivalent scFv display of phagemid repertoires for the selection of carbohydrate-specific antibodies and its application to the Thomsen-Friedenreich antigen.
Ravn P; Danielczyk A; Jensen KB; Kristensen P; Christensen PA; Larsen M; Karsten U; Goletz S
J Mol Biol; 2004 Oct; 343(4):985-96. PubMed ID: 15476815
[TBL] [Abstract][Full Text] [Related]
19. Selection for improved protein stability by phage display.
Jung S; Honegger A; Plückthun A
J Mol Biol; 1999 Nov; 294(1):163-80. PubMed ID: 10556036
[TBL] [Abstract][Full Text] [Related]
20. Design and validation of a synthetic VH repertoire with tailored diversity for protein recognition.
Almagro JC; Quintero-Hernández V; Ortiz-León M; Velandia A; Smith SL; Becerril B
J Mol Recognit; 2006; 19(5):413-22. PubMed ID: 16881059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
